News | Catheters | February 09, 2022

Innovative Health Receives Clearance to Reprocess INTELLAMAP ORION High-Resolution Mapping Catheter

Clearance adds important savings for Innovative Health's partner hospitals

Innovative Health, LLC, a specialty cardiology reprocessor, has announced that the company has received clearance to reprocess Boston Scientific’s INTELLAMAP ORION High-Resolution Mapping Catheter.

February 9, 2022 — Innovative Health, LLC, a specialty cardiology reprocessor, has announced that the company has received clearance to reprocess Boston Scientific’s INTELLAMAP ORION High-Resolution Mapping Catheter. The catheter is widely used in catheter ablation procedures for atrial fibrillation.
 
Innovative Health has built a leading portfolio of FDA clearances to reprocess medical devices in the EP lab and has enabled EP labs across the country to reduce procedure device costs by as much as 30% without compromising patient safety or necessitating treatment adjustments. These savings are strategically important in many EP labs.
 
“EP labs often struggle to pay for new technologies or treat patients under CMS reimbursement, and single-use device reprocessing has presented a strategy for improving care without suffering the usual hardship of cost reduction initiatives,” said Innovative Health CEO Rick Ferreira. “Now, it is up to the EP labs if they want to take advantage of the extra savings.”
 
Innovative Health partner hospitals already save hundreds of thousands of dollars per year by using reprocessed devices from Innovative Health, and in 2021, the number of partner hospitals saving more than $1 million doubled. High-performing hospitals receive Innovative Health’s “Excellence in Electrophysiology” reprocessing award in January and February.
 
Clearance for Boston Scientific’s INTELLAMAP ORION High-Resolution Mapping Catheter means that Innovative Health can now offer every major brand mapping catheter across multiple manufacturers. The FDA clearance can reduce costs by an additional $1,300 in some ablation procedures.
 
For more information: innovative-health.com/

Related Content

Feature | Catheters | By Allied Market Research

According to a new report from Allied Market Research, the global catheters market was valued at $22.7 billion in 2021 ...

Home June 09, 2022
Home
News | Catheters

May 10, 2022 — The MIVI Neuroscience Q Aspiration Catheter incorporates a novel pusher wire design on its proximal end ...

Home May 10, 2022
Home
News | Catheters
April 21, 2022 – MIVI Neuroscience, Inc., innovator of the next generation of neurointerventional medical devices, today ...
Home April 21, 2022
Home
News | Catheters

October 23, 2019 — BioCardia announced the U.S. commercial availability of its Avance Bi-Directional Steerable ...

Home October 23, 2019
Home
Technology | Catheters

August 23, 2019 — Cook Medical recently released the second generation of the 2.6 Fr CXI Support Catheter with platinum ...

Home August 23, 2019
Home
Technology | Catheters

May 16, 2019 — BioCardia Inc. announced U.S. Food and Drug Administration (FDA) 510(k) clearance of the Avance steerable ...

Home May 16, 2019
Home
News | Catheters

February 21, 2019 — Navitian, the new coronary microcatheter from iVascular, recently received CE mark approval. The ...

Home February 21, 2019
Home
News | Catheters

January 31, 2019 — Cardiovascular Systems Inc. announced that the first patients in the United States were treated using ...

Home January 31, 2019
Home
News | Catheters

December 18, 2018 — Merit Medical Systems Inc. announced that it has acquired substantially all of the assets of ...

Home December 18, 2018
Home
News | Catheters

October 2, 2017 — Reflow Medical Inc. announced that the company has received 510(k) clearance from the U.S. Food and ...

Home October 02, 2017
Home
Subscribe Now